Active	Status	Sponsor type	Region	Phase	Filter
2 Active 1 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Vega, Carlos Gonzalez de
NCT04800562: A Clinical Trial to Evaluate PCS499 in Treating Ulcerations in Patients Who Have Necrobiosis Lipoidica	Terminated	2	4	US	PCS499, placebo	Processa Pharmaceuticals	Necrobiosis Lipoidica	02/23	04/23
NCT06101823: Phase 2a Study of Efficacy and Safety of OpSCF in Moderate to Severe Atopic Dermatitis	Active, not recruiting	2	48	Canada, US	OpSCF, Placebo, OpSCF (Open Label Extension)	Opsidio, LLC, Innovaderm Research Inc.	Atopic Dermatitis	10/24	06/25